相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Metformin in breast cancer: preclinical and clinical evidence
Anindita De et al.
CURRENT PROBLEMS IN CANCER (2020)
UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression
James M. Arnold et al.
ONCOGENE (2020)
Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
Shuai Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer
Lan Zhang et al.
EXPERIMENTAL CELL RESEARCH (2020)
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
Qingjian Li et al.
NATURE COMMUNICATIONS (2020)
Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib
Nicla Lorito et al.
CELLS (2020)
TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2
Rong He et al.
GENE (2020)
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese et al.
CANCERS (2020)
Rac1 repression reverses chemoresistance by targeting tumor metabolism
Shanmugasundaram Ganapathy-Kanniappan
CANCER BIOLOGY & THERAPY (2020)
Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
X. X. Jiao et al.
NEOPLASMA (2020)
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer
Lorenzo Castagnoli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis
Chong Chen et al.
ONCOGENE (2019)
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer
Shawn P. Kubli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network
Amanda Valeta-Magara et al.
CANCER RESEARCH (2019)
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
Payal Tiwari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
Fei Chen et al.
NATURE CELL BIOLOGY (2019)
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
Mengjia He et al.
ONCOGENE (2019)
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Deepshikha Mishra et al.
CANCERS (2019)
Effects of hyperglycemia on the progression of tumor diseases
Wenjie Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Chirag H. Patel et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells
Sujin Lee et al.
REDOX BIOLOGY (2019)
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Jiyeon Kim et al.
CELL METABOLISM (2019)
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
Veronica Vella et al.
CELLS (2019)
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias et al.
EUROPEAN JOURNAL OF CANCER (2019)
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
Daniele Cretella et al.
SCIENTIFIC REPORTS (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy
Lingyun Xia et al.
CELL METABOLISM (2019)
Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism
H. A. Zielinska et al.
CANCER LETTERS (2018)
High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis
Daniele Avanzato et al.
CANCER RESEARCH (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
Min Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
K. Kalinsky et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia
L. Morviducci et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
The breast tumor microenvironment: role in cancer development, progression and response to therapy
Suruchi Mittal et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Oncostatin M upregulates HIF-1 alpha in breast tumor associated macrophages independent of intracellular oxygen concentration
Richa Shrivastava et al.
LIFE SCIENCES (2018)
Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
Lijun Jia et al.
LIFE SCIENCES (2018)
Multi-nucleated cells use ROS to induce breast cancer chemoresistance in vitro and in vivo
Aditya Parekh et al.
ONCOGENE (2018)
Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma
Mu Yang et al.
JOURNAL OF CANCER (2018)
Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells
Lin Yang et al.
REDOX BIOLOGY (2018)
4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway
Xu-Na Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer
Fei Huang et al.
CANCER RESEARCH (2018)
Challenges and perspectives in the treatment of diabetes associated breast cancer
Samson Mathews Samuel et al.
CANCER TREATMENT REVIEWS (2018)
Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis
Seher Balaban et al.
MOLECULAR ONCOLOGY (2018)
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
Begoña Martin-Castillo et al.
Oncotarget (2018)
The Influence of Metabolism on Drug Response in Cancer
Esther A. Zaal et al.
FRONTIERS IN ONCOLOGY (2018)
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages
Sara Donzelli et al.
BREAST CANCER RESEARCH (2018)
Diabetes, Obesity, and Breast Cancer
Chifei Kang et al.
ENDOCRINOLOGY (2018)
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
Ran Wei et al.
FOOD & FUNCTION (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner
Ruifang Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Type 2 diabetes, insulin treatment and prognosis of breast cancer
Lan Mu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2
Athba Al Qahtani et al.
ONCOTARGET (2017)
Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients
Raul M. Luque et al.
ONCOTARGET (2017)
The Rac GTPase in Cancer: From Old Concepts to New Paradigms
Marcelo G. Kazanietz et al.
CANCER RESEARCH (2017)
Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin
Qing Chen et al.
ANTI-CANCER DRUGS (2017)
Metformin: historical overview
Clifford J. Bailey
DIABETOLOGIA (2017)
High glucose levels promote the proliferation of breast cancer cells through GTPases
Yilin Hou et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
Gerke Ariaans et al.
BMC CANCER (2017)
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments
Jennifer Ding et al.
CANCER BIOMARKERS (2017)
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor
L. Zeng et al.
ENDOCRINE-RELATED CANCER (2016)
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Kheshwant S. Gill et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Risk factors for cancer development in type 2 diabetes: A retrospective case-control study
Mariusz Dabrowski et al.
BMC CANCER (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Linda S. Steelman et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
Alexander M. Scherbakov et al.
IUBMB LIFE (2016)
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Carly C. Barron et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway
Brendan C. Luey et al.
MOLECULAR CANCER (2016)
Metformin: An anti-diabetic drug to fight cancer
Marie Daugan et al.
PHARMACOLOGICAL RESEARCH (2016)
High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells
Luis Antonio Flores-Lopez et al.
CELLULAR ONCOLOGY (2016)
Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
Kai Hung Tiong et al.
ONCOTARGET (2016)
Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor
Sang Hyeok Woo et al.
ONCOTARGET (2016)
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
Wahyu Wulaningsih et al.
BMC CANCER (2015)
Highly specific role of the insulin receptor in breast cancer progression
Ran Rostoker et al.
ENDOCRINE-RELATED CANCER (2015)
Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
Patrizia Ferroni et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Role of the Tumor Microenvironment in Breast Cancer
Savas D. Soysal et al.
PATHOBIOLOGY (2015)
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Curcumin combined with FAPac vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma
Guan-Min Jiang et al.
ONCOTARGET (2015)
Metformin in breast cancer
Conor A. Bradley
NATURE REVIEWS ENDOCRINOLOGY (2015)
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
Jisun Kim et al.
BMC CANCER (2014)
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α
Ian N. Fleming et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma
Jonathan F. Bean et al.
JOURNAL OF PEDIATRIC SURGERY (2014)
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules
Sirin A. I. Adham et al.
PLOS ONE (2014)
Inflammatory breast cancer: high incidence of detection of mixed human cytomegalovi us genotypes associated with disease pathogenesis
Hossam Taha Mohamed et al.
FRONTIERS IN ONCOLOGY (2014)
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Kristen N. Pollizzi et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models
Sankarganesh Arunachalam et al.
FEBS LETTERS (2013)
Insulin and IGFs in Obesity-Related Breast Cancer
Valentina Belardi et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2013)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tumor M2 pyruvate kinase -: determination in breast cancer patients receiving trastuzumab therapy
M Hoopmann et al.
CANCER LETTERS (2002)
分享论文
